Hall S, Persellin S, Lie J T, O'Brien P C, Kurland L T, Hunder G G
Lancet. 1983 Nov 26;2(8361):1217-20. doi: 10.1016/s0140-6736(83)91269-2.
To evaluate the clinical usefulness of temporal artery biopsy in the diagnosis of giant-cell arteritis we followed up all 134 residents of Olmsted County, Minnesota, who had temporal artery biopsies between 1965 and 1980. Initial biopsies were positive for giant-cell arteritis in 46 cases and negative in 88. A history of jaw pain or claudication and the findings of a palpably abnormal temporal artery were significantly more common in the patients whose biopsy specimens showed giant-cell arteritis. Over a median follow-up period of 70 months (range 1-192) only 8 of the 88 biopsy-negative patients had clinical courses requiring long-term, high-dose corticosteroid therapy for giant-cell arteritis. In this population-based study temporal artery biopsy correctly predicted the subsequent need for corticosteroid therapy in 94% of cases: these findings indicate that biopsy should be done before patients are committed to long-term corticosteroid therapy.
为评估颞动脉活检在巨细胞动脉炎诊断中的临床实用性,我们对明尼苏达州奥姆斯特德县1965年至1980年间接受颞动脉活检的134名居民进行了随访。初次活检结果显示,46例为巨细胞动脉炎阳性,88例为阴性。活检标本显示巨细胞动脉炎的患者中,颌部疼痛或跛行病史以及颞动脉触诊异常的发现明显更为常见。在中位随访期70个月(范围1 - 192个月)内,88例活检阴性患者中只有8例的临床病程需要针对巨细胞动脉炎进行长期、高剂量的皮质类固醇治疗。在这项基于人群的研究中,颞动脉活检在94%的病例中正确预测了随后对皮质类固醇治疗的需求:这些发现表明,应在患者开始长期皮质类固醇治疗之前进行活检。